Rainmaker (RMKR) Awarded Contract Extensions by Two Existing Software Clients for Global B2B e-Commerce Sales

Rexahn Pharmaceuticals (RNN) Secures Approval in Europe to Conduct a First-in-Human Trial of RX-3117 in Solid Tumors

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing oncology and CNS therapeutics, today announced that it has secured Hungarian Regulatory Authority and Ethics Committee approval for Rexahn’s initial Clinical Trial Application (CTA). This allows Rexahn to initiate an exploratory first-in-human Phase I clinical trial of RX-3117.

RX-3117 is a small molecule antimetabolite for the treatment of solid tumors.

“Preclinical studies demonstrate RX-3117 to have exciting anti-cancer properties, and we look forward to moving this compound into clinical development,” said Rick Soni, President and COO of Rexahn. “We will continue to develop RX-3117, which has potential therapeutic applications in a broad range of cancers, including colon, lung and pancreatic cancer.”

In September 2009, Rexahn entered into a commercialization and development agreement with Teva Pharmaceutical Industries Limited for RX-3117. Under the agreement, Rexahn is eligible to receive development, regulatory and sales milestone payments, as well as royalties on net sales worldwide.

About RX-3117

RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that inhibits DNA methyltransferase, a cyclin-dependent kinase, and DNA synthesis. Potential indications of RX-3117 are solid tumors including colon, lung and pancreatic cancers. RX-3117 has demonstrated its ability to overcome cancer drug resistance in cancer cells, in particular, gemcitabine-resistance in the human lung cancer cell. The US and European patent issued for RX-3117 claims composition of matter, synthesis and methods (2008 and 2010, respectively).

About Rexahn Pharmaceuticals, Inc.

Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing and commercializing first in class and market leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. Rexahn currently has three drug candidates in Phase II clinical trials, Archexin®, Serdaxin®, and Zoraxel™, and a robust pipeline of preclinical compounds to treat multiple cancers and CNS disorders. Rexahn also operates key R&D programs of nano-medicines, 3D-GOLD, and TIMES drug discovery platforms. For more information, please visit www.rexahn.com.

Safe Harbor

To the extent any statements made in this press release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about Rexahn’s plans, objectives, expectations and intentions with respect to future operations and products and other statements identified by words such as “will,” “potential,” “could,” “can,” “believe,” “intends,” “continue,” “plans,” “expects,” “anticipates,” “estimates,” “may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause Rexahn’s actual results to be materially different than those expressed in or implied by Rexahn’s forward-looking statements. For Rexahn, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of Rexahn’s licensees or sublicensees; the success of clinical testing; and Rexahn’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect Rexahn’s actual results are described in Rexahn’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. Rexahn undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Mad Catz (MCZ) Signs Licensing Agreement with Sony Computer Entertainment Japan

Mad Catz Interactive, Inc. (“Mad Catz”) (AMEX/TSX: MCZ) announced today that it has entered into a PlayStation_® Accessory Licensing Agreement with SCEJ (Sony Computer Entertainment Japan), a division of Sony Computer Entertainment Inc.

The agreement permits Mad Catz to manufacture and distribute products designed for use with the PlayStation_®3 computer entertainment system and the PlayStation_®Vita portable entertainment system throughout Japan.

“Since we announced the opening of our sales and marketing office in Japan, we have moved rapidly to build brand awareness, localize products and partner with Japanese publishers and developers,” said Darren Richardson, the President and Chief Executive Officer of Mad Catz Interactive, Inc. “Securing a Licensing Agreement with SCEJ is an important step in growing our distribution footprint as we continue our pursuit of growing our international business.”

The first licensed products released throughout Japan as part of the agreement was a selection of licensed PlayStation_®Vita accessories, now shipping throughout the region.

PlayStation is a registered trademark of Sony Computer Entertainment Inc.

About Mad Catz

Mad Catz Interactive, Inc. (AMEX/TSX: MCZ) is a global provider of innovative interactive entertainment products marketed primarily under its Mad Catz^® (casual gaming), Cyborg™ (pro gaming), Tritton^® (gaming audio), Saitek^® (simulation), and Eclipse™ (home and office) brands. Mad Catz also develops flight simulation software through its internal ThunderHawk Studios™; operates flight simulation centers under its Saitek brand; operates a videogame content website under its GameShark^® brand; publishes games under its Mad Catz brand; and distributes games and videogame products for third parties. Mad Catz distributes its products through most leading retailers offering interactive entertainment products and has offices in North America, Europe and Asia. For additional information please go to www.madcatz.com.

Social Media

Facebook: http://www.facebook.com/MadCatzInc

Twitter: http://twitter.com/MadCatzInc

YouTube: http://www.youtube.com/MadCatzCompany

Safe Harbor

This press release contains forward-looking statements about the Company’s business prospects that involve substantial risks and uncertainties. The Company assumes no obligation to update the forward-looking statements contained in this press release as a result of new information or future events or developments. You can identify these statements by the fact that they use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “should,” “plan,” “goal,” “believe,” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Among the factors that could cause actual results to differ materially are the following: the ability to maintain or renew the Company’s licenses; competitive developments affecting the Company’s current products; first party price reductions; the ability to successfully market both new and existing products domestically and internationally; difficulties or delays in manufacturing; or a downturn in the market or industry. A further list and description of these risks, uncertainties and other matters can be found in the Company’s reports filed with the Securities and Exchange Commission and the Canadian Securities Administrators.

Openwave (OPWV) Announces Pursuit of Strategic Alternatives for Products Business

Openwave Systems Inc. (Nasdaq: OPWV), a global software innovator and the inventor of the mobile internet, announced today that its Board of Directors has determined to pursue strategic alternatives for the company’s mediation and messaging products business. The pursuit of strategic alternatives is designed to focus the company on its intellectual property initiative and drive long-term profitability. Openwave has retained Jefferies & Company, Inc. as its exclusive financial advisor in connection with its strategic review.

“We have made significant investments in our products over the past several years. We believe our strategy will enable us to derive the maximum value from our innovative and market-leading messaging and mediation product lines for both our shareholders and our customers,” said Mike Mulica, CEO of Openwave. “Moving forward, we are focusing our efforts on a multi-pronged strategy to realize the value of Openwave’s patents that are foundational to the mobile internet.”

Openwave will make further information available as, and when, a specific transaction or transactions occur.

About Openwave

Openwave Systems Inc. (Nasdaq: OPWV) is a global software innovator and the inventor of the mobile internet. Openwave established many of the foundational patents that allow mobile devices to connect to the Internet. Over the years, the company has built a patent portfolio of approximately 200 patents covering many innovations spanning smart devices, cloud technologies and unified messaging. Today Openwave provides all-Internet Protocol (all-IP) mediation and messaging solutions that enable communication service providers to create and deliver smarter services.

Building on its mobile data heritage, Openwave mobilizes the Internet with data-driven solutions that comprehensively enhance IP traffic and increase the value of the mobile network. Openwave arms its customers with a 360-degree view of network activity plus the tools to help them proactively optimize network resources (Congestion Control), react to user behavior with smarter data plans and services (Price Plan Innovation), and deliver a contextually relevant messaging experience (Converged Messaging).

Openwave is a global company with a blue chip customer base spanning North America, Latin America, Australia and New Zealand, Asia, Africa, Europe, and the Middle East. It holds Openwave is headquartered in Silicon Valley, California.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding Openwave’s expectations regarding its future strategic direction. All statements other than statements of historical fact contained in this press release are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only current predictions and are subject to known and unknown risks, uncertainties and other factors that may cause Openwave’s actual results, levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking statements. These forward-looking statements are subject to a number of risks, including the ability of Openwave to realize anticipated results of its strategy, the ability of Openwave to deliver and capitalize on the opportunities of its strategy, the ability of Openwave to execute its strategy as well as those risk factors discussed in filings with the U.S. Securities and Exchange Commission (“SEC”), including but not limited to the Company’s Annual Report on Form 10-K filed on September 6, 2011, and any subsequently filed reports on Forms 10-Q and 8-K. Openwave undertakes no duty to update or revise any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Broadwind Energy (BWEN) Wins $23 Million Tower Order

Broadwind Energy, Inc. (NASDAQ: BWEN) today announced strong fourth-quarter orders, including a $23 million order for wind turbine towers. The tower order was Broadwind’s first order from a leading U.S. wind turbine manufacturer and will encompass towers for various domestic wind projects. The towers will be produced in Broadwind’s Manitowoc, Wisconsin facility for delivery during the second half of 2012.

President & CEO Peter Duprey stated, “Fourth-quarter orders were strong across each of our business segments including gearing, towers and services. We are well positioned for revenue growth in 2012. We are delighted to win our first tower order with a major new customer—this fits with our strategy to further diversify our customer base.”

About Broadwind Energy, Inc.

Broadwind Energy (NASDAQ: BWEN) applies decades of deep industrial expertise to innovate integrated solutions for customers in the energy and infrastructure markets. From gears and gearing systems for wind, oil and gas and mining applications to wind towers, to comprehensive remanufacturing of gearboxes and blades, to operations and maintenance services, and specialty weldments, we have solutions for the energy needs of the future. With facilities throughout the U.S., Broadwind Energy’s talented team of 800 employees is committed to helping customers maximize performance of their investments—quicker, easier and smarter. Find out more at www.bwen.com.

Forward-Looking Statements

This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995—that is, statements related to future, not past, events. Forward-looking statements are based on current expectations and include any statement that does not directly relate to a current or historical fact. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “anticipate,” “believe,” “intend,” “expect,” “plan,” “will” or other similar words. These forward-looking statements involve certain risks and uncertainties that ultimately may not prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. The Company’s forward looking statements may include or relate to the Company’s plans to grow its business and its expectations regarding its operations, revenue growth and the business of its customers; the Company’s expectations regarding its plan to restructure its operations by consolidating its operations; the sufficiency of the Company’s working capital; and the Company’s expectations regarding the state of the wind energy market generally, as well as the Company’s expectations relating to the economic downturn and the potential impact on its business and the business of its customers. For further discussion of risks and uncertainties, individuals should refer to the Company’s SEC filings. The Company undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this news release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. All forward-looking statements are qualified in their entirety by this cautionary statement.

China GrenTech (GRRF) Enters Into Definitive Agreement With Talenthome Management Ltd. and Xing Sheng Corp. Ltd.

SHENZHEN, China, Jan. 12, 2012 /PRNewswire-Asia-FirstCall/ — China GrenTech Corporation Limited (NASDAQ: GRRF, “GrenTech,” or the “Company”), a leading China-based provider of radio frequency and wireless coverage products and services, today announced that it has entered into an agreement and plan of merger (the “Merger Agreement”) with Talenthome Management Limited (“Parent”), a British Virgin Islands exempted company, and Xing Sheng Corporation Limited (“Merger Sub”), a Cayman Islands exempted company wholly-owned by Parent. Parent is jointly owned indirectly by Mr. Yingjie Gao, the Company’s Chairman and Chief Executive Officer, Ms. Rong Yu, the Company’s Director and Chief Financial Officer, and Ms. Yin Huang (together, the “Buyer Group”). The Buyer Group collectively beneficially owns approximately 41.9% of the Company’s issued and outstanding ordinary shares and intends to finance the merger and the other transactions contemplated by the Merger Agreement through proceeds from a loan facility in the amount of HK$320,000,000 from Guotai Junan Finance (Hong Kong) Limited.

Pursuant to the Merger Agreement, (i) upon the terms and subject to the conditions set forth therein, at the effective time of the merger, Merger Sub will be merged with and into the Company and the Company will become a wholly-owned subsidiary of Parent, and (ii) each ordinary share of the Company (including ordinary shares represented by American Depositary Shares (“ADSs”), each of which represents 25 ordinary shares) issued and outstanding immediately prior to the effective time of the merger will be cancelled in exchange for the right to receive US$0.126 (or US$3.15 per ADS) in cash without interest, except for the ordinary shares (including ordinary shares represented by ADSs) (x) beneficially owned by the Buyer Group, which will be cancelled without receiving any consideration, and (y) owned by holders of such ordinary shares who have validly exercised and not effectively withdrawn or lost their appraisal rights pursuant to Section 238 of the Cayman Islands Companies Law, as amended. This represents a 23.0% premium over the closing price as quoted by Bloomberg L.P. on November 11, 2011 and a 40.6% over the 60-trading day volume weighted average price as quoted by Bloomberg L.P. on November 11, 2011, the last trading day prior to the Company’s announcement on November 14, 2011 that it had received a “going private” proposal.

The Company’s Board of Directors, acting upon the unanimous recommendation of the Independent Committee formed by the Board of Directors, approved the Merger Agreement and the merger contemplated in the Merger Agreement and resolved to recommend that the Company’s shareholders vote to approve and adopt the Merger Agreement and the merger. The Independent Committee, which is composed solely of directors unrelated to Parent, Merger Sub or any of the management members of the Company, negotiated the terms of the Merger Agreement with the assistance of its financial and legal advisors.

The merger contemplated in the Merger Agreement, which is currently expected to close before the end of the second quarter of 2012, is subject to the approval by an affirmative vote of shareholders representing two-thirds or more of the ordinary shares present and voting in person or by proxy at a meeting of the Company’s shareholders which will be convened to consider the approval and adoption of the Merger Agreement and the merger, as well as certain other customary closing conditions. The Buyer Group has agreed to vote to approve the Merger Agreement and the merger. If completed, the merger will result in the Company becoming a privately-held company and its ADSs would no longer be listed on the NASDAQ Global Select Market.

William Blair & Company, L.L.C. is serving as financial advisor to the Independent Committee. Cleary Gottlieb Steen & Hamilton LLP is serving as United States legal advisor to the Independent Committee and Conyers Dill & Pearman is serving as Cayman Islands legal advisor to the Independent Committee. Ropes & Gray LLP is serving as United States legal advisor to the Company. Skadden, Arps, Slate, Meagher & Flom LLP is serving as United States legal advisor to the Buyer Group. McDermott Will & Emery LLP is serving as United States legal advisor to William Blair & Company, L.L.C.

Additional Information about the Transaction
The Company will furnish to the Securities and Exchange Commission (the “SEC”) a report on Form 6-K regarding the proposed merger, which will include the Merger Agreement and related documents. All parties desiring details regarding the proposed merger are urged to review these documents, which are available at the SEC’s website (http://www.sec.gov).

In connection with the proposed merger, the Company will prepare and mail a proxy statement to its shareholders. In addition, certain participants in the proposed merger will prepare and mail to the Company’s shareholders a Schedule 13E-3 transaction statement. These documents will be filed with or furnished to the SEC. INVESTORS AND SHAREHOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THESE MATERIALS AND OTHER MATERIALS FILED WITH OR FURNISHED TO THE SEC WHEN THEY BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, THE PROPOSED MERGER AND RELATED MATTERS. In addition to receiving the proxy statement and Schedule 13E-3 transaction statement by mail, shareholders also will be able to obtain these documents, as well as other filings containing information about the Company, the proposed merger and related matters, without charge, from the SEC’s website (http://www.sec.gov) or at the SEC’s public reference room at 100 F Street, NE, Room 1580, Washington, D.C. 20549. In addition, these documents can be obtained, without charge, by contacting the Company at the following address and/or phone number:

China GrenTech Corporation Limited
15th Floor, Block A, Guoren Building
Keji Central 3rd Road
Hi-Tech Park, Nanshan District
Shanghai 518057, People’s Republic of China
Telephone: (86 755) 2650-3007

The Company and certain of its directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be “participants” in the solicitation of proxies from our shareholders with respect to the proposed merger. Information regarding the persons who may be considered “participants” in the solicitation of proxies will be set forth in the proxy statement and Schedule 13E-3 transaction statement relating to the proposed merger when it is filed with the SEC. Additional information regarding the interests of such potential participants will be included in the proxy statement and Schedule 13E-3 transaction statement and the other relevant documents filed with the SEC when they become available.

This announcement is neither a solicitation of proxy, an offer to purchase nor a solicitation of an offer to sell any securities and it is not a substitute for any proxy statement or other filings that may be made with the SEC should the proposed merger proceed.

About China GrenTech
GrenTech is a leading developer of radio frequency (“RF”) technology in China and a leading provider of wireless coverage products and services in China. The Company uses RF technology to design and manufacture wireless coverage products, which enables telecommunications operators to expand the reach of their wireless communication networks to indoor and outdoor areas such as buildings, highways, subways, tunnels and remote regions. China GrenTech’s wireless coverage services include design, installation and project warranty services. The Company also tailors the design and configuration of its wireless coverage products to the specific requirements of its customers.

Based on its in-house RF technology platform, the Company also develops and produces base station RF parts and components sold to base station manufacturers. GrenTech is a qualified supplier of RF parts and components to major global and domestic base station manufacturers. For more information, please visit www.GrenTech.com.cn.

Safe Harbor Statement
Certain statements contained in this announcement may be viewed as “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual performance, financial condition or results of operations of GrenTech to be materially different from any future performance, financial condition or results of operations implied by such forward-looking statements. The accuracy of these statements may be impacted by a number of business risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, and other risks outlined in GrenTech’s filings with the U.S. Securities and Exchange Commission, including its registration statement on Form F-1 and annual reports on Form 20-F. GrenTech undertakes no ongoing obligation, other than that imposed by law, to update these statements.

Quest (QRM) Reports Strong Summer Program Drill Results at Strange Lake, Intersects 144.4 Metres at 1.44% TREO

TORONTO, ONTARIO — (Marketwire) — 01/12/12 — Quest Rare Minerals Ltd. (TSX VENTURE:QRM)(NYSE Amex:QRM) is pleased to report the assay results from the 2011 definition diamond drilling program completed on its Strange Lake B-Zone Rare Earth Element (REE) deposit. Final lab results for holes BZ-11-118 to BZ-11-255 have returned multiple, high-grade Total Rare Earth Oxide (TREO) intersections of between 1.12% and 6.11% over thicknesses of 2.34 m to 147.0 m. Heavy Rare Earth Oxide (HREO) represents between 22.4% and 76.5% of the TREO content intersected in the new drilling. Best intersection grades returned 1.44% TREO over 144.4 m (BZ11218); 1.23% TREO over 116.1 m (BZ11189), including 3.04% TREO over 11.7 m and 4.9% TREO over 4.9 m; and 1.18% TREO over 95.9 m (BZ11135), including 1.48% TREO over 45.6 m and 3.29% TREO over 9.9 m. Important enrichment in zirconium (ZrO2), niobium (Nb2O5) and hafnium (HfO2) continues to characterize mineralization. The detailed drill sample analysis table and typical diamond drill sections are available on Quest’s website homepage at www.questrareminerals.com.

“Our 2011 definition program has now provided Quest with the confidence of good continuity and grade of the B-Zone deposit within the pit shell outline established by our April 2011 Revised Resource Estimate,” said Peter Cashin, Quest’s President & CEO. “Our exploration efforts will now focus on upgrading our Indicated and Inferred Resource into Proven and Probable Reserves, to be used in the pre-feasibility study now underway for the B-Zone. We have now defined sufficient resources to more than satisfy the minimum 25-year production model established by the Preliminary Economic Assessment report delivered in 2010. Geotechnical and metallurgical drilling in support of our pre-feasibility study was also completed during the 2011 field season.”

B-Zone Definition Drill Program

Assays have been received for 138 diamond drill holes representing 17,110.4 m (see Table 1). The drilling program tested the extent of B-Zone mineralization to the limits of the Whittle Pit shell established by Quest’s 43-101 Revised Resource Estimate (see Press Release : April 13, 2011), on a 50 m by 50 m drilling pattern (see Figure 1). The new drilling was focused on tight definition of the upper 150 m of the deposit, although mineralization is observed to continue down to 325 m vertical. In addition to enlarging the peripheral limits to the deposit within the pit shell, drilling indicates that good higher-grade Pegmatite-style mineralization continues to the southwest, past the established limit to the pit shell (see Figure 2). In addition to the definition drilling, 53 holes for 4,772.0 m were completed for metallurgical testing purposes across the full extent of mineralization defined within the pit shell as well as for geotechnical testing. This data will be used in the pre-feasibility study currently underway on the B-Zone.

The best results from the definition drill program (see Table 1 for drillhole locations) are:

----------------------------------------------------------------------------
                                 Length                                    %
HOLE-ID           FROM      TO      (m)   TREO%   LREO%   HREO%  (HREO/TREO)
----------------------------------------------------------------------------
BZ11118          12.86   54.47    41.61  1.6260  0.8491  0.7769        47.78
----------------------------------------------------------------------------
including        18.30   30.57    12.27  2.3812  1.1662  1.2150        51.03
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11122           9.00  115.19   106.19  1.1078  0.6264  0.4814        43.46
----------------------------------------------------------------------------
including        27.18   44.00    16.82  1.7909  0.7524  1.0387        58.00
----------------------------------------------------------------------------
and including    27.18   34.90     7.72  2.7055  1.0407  1.6649        61.54
----------------------------------------------------------------------------
and including    84.41   96.10    11.69  1.3249  0.7121  0.6130        46.27
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11124          16.80   72.40    55.60  1.1349  0.6233  0.5115        45.07
----------------------------------------------------------------------------
including        16.80   32.50    15.70  1.4139  0.8132  0.6007        42.48
----------------------------------------------------------------------------
and including    69.18   72.40     3.22  2.4528  1.1808  1.2714        51.83
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11125           2.82  126.00   123.18  1.1257  0.5773  0.5484        48.72
----------------------------------------------------------------------------
including        19.80   37.25    17.45  2.5327  0.8238  1.7088        67.47
----------------------------------------------------------------------------
and including    27.60   35.25     7.65  3.6087  0.9373  2.6714        74.03
----------------------------------------------------------------------------
and including    79.94   97.50    17.56  1.0490  0.6454  0.4036        38.47
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11126           3.00  126.00   123.00  1.0726  0.5951  0.4773        44.50
----------------------------------------------------------------------------
including        31.00   60.64    29.64  1.8610  0.9088  0.9522        51.16
----------------------------------------------------------------------------
and including    31.00   39.71     8.71  2.4447  1.0988  1.3456        55.04
----------------------------------------------------------------------------
and including    50.46   55.36     4.90  3.6769  1.8551  1.8218        49.55
----------------------------------------------------------------------------
and including    50.46   60.64    10.18  2.3681  1.2265  1.1416        48.21
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11135           1.25   97.00    95.75  1.1843  0.6218  0.5626        47.50
----------------------------------------------------------------------------
including         4.75   50.36    45.61  1.4832  0.6760  0.8073        54.43
----------------------------------------------------------------------------
and including    40.50   50.36     9.86  3.2870  1.0947  2.1922        66.69
----------------------------------------------------------------------------
and including     4.75    6.58     1.83  3.3806  1.6622  1.7179        50.82
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11138           2.30  126.00   123.70  1.0830  0.6115  0.4717        43.55
----------------------------------------------------------------------------
including         2.30   45.00    42.70  1.3366  0.7258  0.6109        45.70
----------------------------------------------------------------------------
and including     6.73   17.34    10.61  1.5308  0.7573  0.7734        50.52
----------------------------------------------------------------------------
and including    27.86   36.00     8.14  1.6422  0.9113  0.7310        44.51
----------------------------------------------------------------------------
and including    92.00  109.64    17.64  1.2895  0.7180  0.5715        44.32
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11141           3.77  126.00   122.23  1.1390  0.6134  0.5256        46.14
----------------------------------------------------------------------------
including         3.77   47.36    43.59  1.5088  0.6900  0.8188        54.27
----------------------------------------------------------------------------
and including     9.33   27.00    17.67  1.8384  0.8029  1.0356        56.33
----------------------------------------------------------------------------
and including    20.31   27.00     6.69  2.2973  0.9061  1.3910        60.55
----------------------------------------------------------------------------
and including    44.00   47.36     3.36  3.2102  1.1954  2.0148        62.76
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11143           1.69  126.00   124.31  1.1291  0.6668  0.4623        40.94
----------------------------------------------------------------------------
including        46.87   64.00    17.13  2.7298  1.5151  1.2148        44.50
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11150           9.20  111.00   101.80  1.0993  0.6641  0.4352        39.59
----------------------------------------------------------------------------
including        45.94   59.25    13.31  1.9343  0.9742  0.9600        49.63
----------------------------------------------------------------------------
and including    53.89   59.25     5.36  2.1683  0.8414  1.3270        61.20
----------------------------------------------------------------------------
and including    75.50   81.68     6.18  1.4024  0.8750  0.5278        37.64
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11164           6.00  126.00   120.00  1.0924  0.5848  0.5076        46.47
----------------------------------------------------------------------------
including        23.90   73.65    49.75  1.4425  0.6794  0.7631        52.90
----------------------------------------------------------------------------
and including    58.98   60.55     1.57  2.0250  1.1133  0.9118        45.02
----------------------------------------------------------------------------
and including    68.45   73.65     5.20  4.1464  1.4708  2.6756        64.53
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11176           6.49  150.00   143.51  1.0957  0.6054  0.4903        44.75
----------------------------------------------------------------------------
including        11.00   60.35    49.35  1.3325  0.6583  0.6741        50.59
----------------------------------------------------------------------------
and including    22.16   60.35    38.19  1.4486  0.6917  0.7570        52.25
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11189           9.90  126.00   116.10  1.2293  0.7328  0.4965        40.39
----------------------------------------------------------------------------
including        32.54   36.48     3.94  4.9015  2.3843  2.5172        51.36
----------------------------------------------------------------------------
and including    76.66   88.34    11.68  3.0352  1.5811  1.4541        47.91
----------------------------------------------------------------------------

----------------------------------------------------------------------------
BZ11218           5.65  150.00   144.35  1.1437  0.6226  0.5211        45.56
----------------------------------------------------------------------------
including        17.60   18.60     1.00  3.1681  2.4576  0.7105        22.43
----------------------------------------------------------------------------
and including    34.48   40.48     6.00  2.0526  0.7954  1.2572        61.25
----------------------------------------------------------------------------
and including   118.15  126.15     8.00  2.6715  1.2857  1.3858        51.87
----------------------------------------------------------------------------

BZ11228           3.30  126.00   122.70  1.1060  0.6576  0.4484        40.54
----------------------------------------------------------------------------
including         4.60   58.41    53.81  1.3265  0.7528  0.5737        43.25
----------------------------------------------------------------------------
and including    24.50   30.65     6.15  2.0825  1.2053  0.8772        42.12
----------------------------------------------------------------------------
and including    38.38   44.60     6.22  1.9376  0.9378  0.9998        51.60
----------------------------------------------------------------------------
Where: TREO=Total Rare Earth Oxides, includes Y2O3=yttrium oxide (i),
La2O3=lanthanum oxide (i), Ce2O3=cerium oxide (i), Pr2O3=praseodymium
oxide (i), Nd2O3=neodymium oxide (i), Sm2O3=samarium oxide,
Eu2O3=europium oxide, Gd2O3=gadolinium oxide, Tb2O3=terbium oxide (i),
Dy2O3=dysprosium oxide (i), Ho2O3=holmium oxide, Er2O3=erbium oxide,
Tm2O3=thulium oxide (i), Yb2O3=ytterbium oxide, Lu2O3=lutetium oxide
(i); LREO=light rare earth oxides, includes La2O3=lanthanum oxide,
Ce2O3=cerium oxide, Pr2O3=praseodymium oxide, Nd2O3=neodymium oxide,
Sm2O3=samarium oxide; HREO=heavy rare earth oxides, includes Y2O3=yttrium
oxide, Eu2O3=europium oxide, Gd2O3=gadolinium oxide, Tb2O3=terbium oxide,
Dy2O3=dysprosium oxide, Ho2O3=holmium oxide, Er2O3=erbium oxide,
Tm2O3=thulium oxide, Yb2O3=ytterbium oxide, Lu2O3=lutetium oxide. The
principal REO at the B-Zone are depicted by an asterisk (i).

The better grades of mineralization are associated with what is termed Pegmatite-style material, which is composed of a high proportion of pegmatite sheets that are intercalated with extremely-altered Strange Lake peralkaline granite at the uppermost parts of the B-Zone mineralized system. The highly-altered, granite-hosted zones continue to carry elevated grades of REE in excess of 0.7% TREO over core lengths of more than 314.6 m (see Press Release: December 9, 2010). These grades exceed the economic cut-off of 0.58% TREO determined for the deposit by Quest’s Revised Resource Estimate for the B-Zone (see Press Release: April 13, 2011).

2012 Exploration Program

Plans for upcoming winter and summer exploration programs on the B-Zone are well advanced and will include 15,000 m of exploration and geotechnical drilling, prospecting, geological mapping and rock sampling as well as the collection of additional bulk sample material to supplement an 18-tonne sample currently in storage. This material will be used for the planned Pilot Mill testing program to be undertaken once the metallurgical flow sheet for the B-Zone has been finalized. In addition, preliminary engineering and baseline environmental work for use in the current pre-feasibility study for the B-Zone will continue. As well, parallel-path data collection for use in the subsequent bankable feasibility study (BFS) of the B-Zone has been undertaken as a means to fast-track completion of the BFS. The exploration drilling will focus on defining additional areas of surface high grade Pegmatite-style mineralization on five priority targets located on the Strange Lake property.

Quality Control

Mr. Peter Cashin, P. Geo., is the qualified person on the Strange Lake Project under National Instrument 43-101 and is responsible for this news release. Material for analysis has been obtained from drill core which was cut in half using a diamond saw. Half of the core was sent to the lab for analysis, with the remaining half left on-site for future reference. A strict QA/QC program is followed which includes the use of elemental standards, duplicates and blanks. Analyses were performed by Activation Laboratory Limited of Ancaster, Ontario.

About Quest Rare Minerals

Quest Rare Minerals Ltd. is a Canadian-based exploration company focused on the identification and discovery of new and significant Rare Earth deposit opportunities. Quest is publicly listed on the TSX Venture Exchange and NYSE Amex as “QRM” and is led by a highly-respected management and technical team with a proven mine finding track record. Quest is currently advancing several high-potential projects in Canada’s premier exploration areas: the Strange Lake and Misery Lake areas of northeastern Quebec and the Plaster Rock area of northwestern New Brunswick. Quest’s 2009 exploration led to the discovery of a significant new Rare Earth metal deposit, the B-Zone, on its Strange Lake property in northeastern Quebec. Quest recently filed a 43-101 Indicated and Inferred Resource Estimate on the B-Zone deposit and has completed a Preliminary Economic Assessment (PEA) for the deposit. In addition, Quest announced the discovery of an important new area of REE mineralization on its Misery Lake project, approximately 120 km south of Strange Lake project. Quest continues to pursue high-value project opportunities throughout North America. As a result of a marketed equity financing completed in October 2010, Quest has a strong working capital position of $44.5 million. This will be sufficient to advance Quest’s plans of completing pre-feasibility and bankable feasibility studies of the B-Zone REE deposit and to continue exploration on its other rare earth properties.

Forward-Looking Statements

This news release contains statements that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities legislation. Forward-looking information and statements may include, among others, statements regarding the future plans, costs, objectives or performance of Quest Rare Minerals Ltd. (“Quest”), or the assumptions underlying any of the foregoing. In this news release, words such as “may”, “would”, “could”, “will”, “likely”, “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate” and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur, or if any of them do so, what benefits that Quest will derive. Forward-looking statements and information are based on information available at the time and/or management’s good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Quest’s control. These risks, uncertainties and assumptions include, but are not limited to, those described under “Risk Factors” in Quest’s annual information form dated March 2, 2011, and under the heading “Risk Factors” in Quest’s Management’s Discussion and Analysis for the quarter ended July 31, 2011, both of which are available on SEDAR at www.sedar.com and on EDGAR at www.sec.gov, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Quest does not intend, nor does Quest undertake any obligation, to update or revise any forward-looking information or statements contained in this news release to reflect subsequent information, events or circumstances or otherwise, except if required by applicable laws.

To view Figure 1 – Geological and Diamond Drilling Compilation Map, B-Zone REE Deposit, Strange Lake Project, Quebec, please visit the following link: http://media3.marketwire.com/docs/758047_fig_1.pdf

To view Figure 2 – Cumulative Thickness Isopach Map of Pegmatite-style Mineralization, B-Zone REE Deposit, Strange Lake, Quebec, please visit the following link: http://media3.marketwire.com/docs/758047_fig_2.pdf

 Table 1 - Summer Diamond Drillhole Location Table, B-Zone Deposit, Strange
                                Lake, Quebec
----------------------------------------------------------------------------

HOLE-ID       Easting   Northing  Elevation (m)    Length      Dip   Azimuth
----------------------------------------------------------------------------
BZ11118        427980    6243074            449    125.30   -90.00      0.00
BZ11119        428027    6243000            457    114.05   -90.00      0.00
BZ11120        428063    6242949            463    117.00   -90.00      0.00
BZ11121        428094    6242897            472    117.00   -90.00      0.00
BZ11122        427967    6243023            454    115.19   -90.00      0.00
BZ11123        427994    6242969            459    117.00   -90.00      0.00
BZ11124        428022    6242910            468    126.00   -90.00      0.00
BZ11125        428063    6242837            480    126.00   -90.00      0.00
BZ11126        428087    6242794            487    126.00   -90.00      0.00
BZ11127        428111    6242750            496    126.00   -90.00      0.00
BZ11128        428134    6242711            504    126.00   -90.00      0.00
BZ11129        428158    6242667            513    123.00   -90.00      0.00
BZ11130        428189    6242611            525    126.00   -90.00      0.00
BZ11131        428147    6242599            525     99.00   -90.00      0.00
BZ11132        428127    6242633            521    117.00   -90.00      0.00
BZ11133        428025    6242813            481     99.00   -90.00      0.00
BZ11134        427998    6242866            473    151.00   -90.00      0.00
BZ11135        428058    6242756            492     97.00   -90.00      0.00
BZ11136        427965    6242922            463    150.00   -90.00      0.00
BZ11137        427932    6242876            468    150.00   -90.00      0.00
BZ11138        427961    6242819            475    126.00   -90.00      0.00
BZ11139        428005    6242744            490    129.00   -90.00      0.00
BZ11140        427862    6242894            461    124.74   -65.00    150.00
BZ11141        427909    6242815            473    126.00   -90.00      0.00
BZ11142        427856    6243003            450    126.00   -90.00      0.00
BZ11143        428031    6242702            496    126.00   -90.00      0.00
BZ11144        427945    6242751            485    126.00   -90.00      0.00
BZ11145        427981    6242693            494    126.00   -90.00      0.00
BZ11146        428057    6242657            504    125.30   -90.00      0.00
BZ11147        427902    6242942            458    125.80   -65.00    150.00
BZ11148        428023    6242617            505    100.50   -90.00      0.00
BZ11149        428086    6242607            521    101.00   -90.00      0.00
BZ11150        428051    6243067            451    111.00   -90.00      0.00
BZ11151        428107    6242574            525     97.27   -90.00      0.00
BZ11152        428054    6242571            521     99.00   -90.00      0.00
BZ11153        427872    6242980            451    150.00   -65.00    150.00
BZ11154        428075    6242531            527     99.00   -90.00      0.00
BZ11155        428034    6242492            532    150.00   -90.00      0.00
BZ11156        427813    6242943            452    117.00   -65.00    150.00
BZ11157        427993    6242456            533    102.06   -90.00      0.00
BZ11158        428002    6242538            515    102.00   -90.00      0.00
BZ11159        428098    6243015            458    117.00   -90.00      0.00
BZ11160        427988    6242583            508    102.00   -90.00      0.00
BZ11161        428162    6242880            479     90.45   -90.00      0.00
BZ11162        427787    6242918            453    126.00   -65.00    150.00
BZ11163        428135    6242825            486    101.70   -90.00      0.00
BZ11164        427959    6242625            499    126.00   -90.00      0.00
BZ11165        428136    6243018            460    123.00   -90.00      0.00
BZ11166        427970    6242510            514    111.00   -90.00      0.00
BZ11167        427814    6242874            461    126.00   -90.00      0.00
BZ11168        428139    6243117            450    126.00   -65.00    150.00
BZ11169        428168    6242967            465    101.70   -90.00      0.00
BZ11170        427915    6242698            489    127.30   -90.00      0.00
BZ11171        427840    6242829            466    126.00   -65.00    150.00
BZ11172        428202    6242914            476    101.76   -90.00      0.00
BZ11173        427989    6242582            508     80.00   -90.00      0.00
BZ11174        428163    6243072            455    123.00   -90.00      0.00
BZ11175        427931    6242584            504    124.44   -90.00      0.00
BZ11176        427894    6242643            495    150.00   -90.00      0.00
BZ11177        428191    6243028            460    126.00   -90.00      0.00
BZ11178        428217    6242983            467     97.86   -90.00      0.00
BZ11179        428242    6242941            476     98.81   -90.00      0.00
BZ11180        427745    6242901            454    126.00   -65.00    150.00
BZ11181        428324    6242988            473    102.00   -90.00      0.00
BZ11182        428301    6243034            467     99.00   -90.00      0.00
BZ11183        427897    6242537            512    150.00   -90.00      0.00
BZ11184        428278    6243077            460    126.00   -90.00      0.00
BZ11185        427702    6242876            460    126.00   -65.00    150.00
BZ11186        428253    6243120            455    106.36   -90.00      0.00
BZ11187        427777    6242746            473    125.50   -90.00      0.00
BZ11188        427975    6242427            539    147.00   -90.00      0.00
BZ11189        428228    6243164            452    126.00   -90.00      0.00
BZ11190        428295    6243148            455    126.00   -90.00      0.00
BZ11191        427722    6242841            465    126.00   -65.00    125.80
BZ11192        428207    6243100            456    125.90   -90.00      0.00
BZ11193        428340    6243171            452    125.33   -90.00      0.00
BZ11194        427922    6242494            517    102.00   -90.00      0.00
BZ11195        427752    6242789            469    123.00   -90.00      0.00
BZ11196        428238    6243047            463    126.00   -90.00      0.00
BZ11197        428365    6243127            460    126.00   -90.00      0.00
BZ11198        427694    6242388            517    126.20   -90.00      0.00
BZ11199        427813    6242582            500    123.00   -90.00      0.00
BZ11200        427709    6242763            470    126.00   -65.00    150.00
BZ11201        427866    6242492            514    102.00   -90.00      0.00
BZ11203        427625    6242409            507    125.00   -90.00      0.00
BZ11204        427791    6242420            518    126.00   -90.00      0.00
BZ11205        427744    6242301            528    153.00   -90.00      0.00
BZ11206        427842    6242433            521    102.00   -90.00      0.00
BZ11207        427786    6242329            528    102.00   -90.00      0.00
BZ11208        428378    6242903            493     99.44   -90.00      0.00
BZ11209        427673    6242726            465    105.00   -65.00    150.00
BZ11210        427761    6242372            521    102.00   -90.00      0.00
BZ11211        427719    6242345            523    126.00   -90.00      0.00
BZ11212        427769    6242259            534    141.00   -90.00      0.00
BZ11213        427682    6242211            535    150.00   -90.00      0.00
BZ11214        427725    6242235            534    126.00   -90.00      0.00
BZ11215        427675    6242621            475    126.00   -65.00    150.00
BZ11216        427736    6242415            515    126.00   -90.00      0.00
BZ11217        427650    6242366            517    141.00   -90.00      0.00
BZ11218        427715    6242552            495    150.00   -65.00    150.00
BZ11219        427711    6242459            509    147.22   -90.00      0.00
BZ11220        427817    6242476            514    126.00   -90.00      0.00
BZ11221        427686    6242502            501    135.00   -90.00      0.00
BZ11222        427742    6242503            503    150.00   -65.00    150.00
BZ11223        427791    6242519            507    126.00   -90.00      0.00
BZ11224        427661    6242545            494    126.00   -90.00      0.00
BZ11225        427727    6242631            483    126.00   -90.00      0.00
BZ11226        427891    6242447            521    123.39   -90.00      0.00
BZ11227        427697    6242682            468    120.00   -65.00    150.00
BZ11228        427886    6242754            477    126.00   -90.00      0.00
BZ11229        427644    6242474            498    150.00   -65.00    150.00
BZ11230        428267    6242896            486    101.74   -90.00      0.00
BZ11231        427751    6242691            476    126.00   -65.00    150.00
BZ11232        428354    6242948            483    100.67   -90.00      0.00
BZ11233        428169    6242765            498    102.00   -90.00      0.00
BZ11234        427581    6242383            511    123.00   -90.00      0.00
BZ11235        427746    6242598            492    125.75   -90.00      0.00
BZ11236        428203    6242707            516     99.00   -90.00      0.00
BZ11237        428335    6243079            465    126.00   -90.00      0.00
BZ11238        427611    6242632            477    138.26   -90.00      0.00
BZ11239        428185    6242836            489    102.00   -90.00      0.00
BZ11240        427607    6242340            518    149.53   -90.00      0.00
BZ11241        428265    6243201            455    126.00   -65.00    330.00
BZ11242        427635    6242590            487    141.00   -90.00      0.00
BZ11243        427675    6242322            522    148.00   -90.00      0.00
BZ11244        427617    6242723            471    125.80   -65.00    150.00
BZ11245        427678    6242816            465    126.00   -90.00      0.00
BZ11246        427632    6242297            525    174.00   -90.00      0.00
BZ11248        427595    6242561            488    150.00   -65.00    150.00
BZ11249        427620    6242517            494    165.00   -65.00    150.00
BZ11250        427563    6242315            520    145.33   -90.00      0.00
BZ11251        427600    6242452            501    150.00   -90.00      0.00
BZ11252        427657    6242254            532    150.00   -90.00      0.00
BZ11253        427613    6242228            533    150.00   -90.00      0.00
BZ11254        427700    6242279            530    148.75   -90.00      0.00
BZ11255        427588    6242272            526    150.00   -90.00      0.00
                     ------------------------------------
                          TOTALS            138  17110.40
                     ------------------------------------

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
Quest Rare Minerals Ltd.
Peter J. Cashin
President & CEO
(416) 916-0777 or Toll-Free: 1-877-916-0777
(416) 916-0779 (FAX)
info@questrareminerals.com
www.questrareminerals.com

SolarFocus (ENER) Launches UNI-SOLAR(R) Powered Kindle(TM) Cover at CES in Las Vegas

AUBURN HILLS, Mich., Jan. 12, 2012 (GLOBE NEWSWIRE) — United Solar, the global manufacturer of UNI-SOLAR® lightweight, flexible solar products and a wholly owned subsidiary of Energy Conversion Devices, Inc. (ECD) (Nasdaq:ENER) is proud to announce today the commercial launch of the world’s first solar-powered cover for the Amazon Kindle™ e-reader by SolarFocus Technology Co., Ltd., a leader in solar-powered portable products.

SolarFocus’ SolarKindle Lighted Cover uses UNI-SOLAR‘s proprietary technology to charge the Kindle’s internal battery as well as the cover’s integrated reserve battery, which is used to power the LED reading light featured on the inside of the cover. The solar cells, located on the front of the leather cover, are charged from direct exposure to the sun, providing unlimited extended power to the device.

The SolarKindle Lighted Cover will be revealed at the International Consumer Electronics Show (CES) this week (January 10-13, 2012) in Las Vegas, Nevada. The lightweight solar cover will be recognized as a 2012 Innovations Honoree in the Eco-Design and Sustainability Technologies category. The CES is hosted by the Consumer Electronics Association (CEA) and showcases the ground-breaking products and technologies influencing consumer technology.

“The SolarKindle Lighted Cover is a great example of the success of United Solar’s Open Solar™ initiative, which allows our strategic partner, SolarFocus, to leverage the differentiation of our unique high-performance, lightweight and flexible solar cells,” said Chris Bala, Vice President of Sales-Open Solar. “This innovative product represents just how easily UNI-SOLAR technology can be integrated seamlessly and cost effectively into everyday applications.”

The SolarKindle Lighted Cover is available on the web at SolarFocus’ webstore, solarmio.com, and at amazon.com. The product will be available through specialty retail outlets in the U.S., Canada and Europe in 2012.

United Solar, with more than 25 years experience in the solar industry, is the largest manufacturer of light weight, flexible solar panels in the world, and has been awarded nearly 70 United States patents for various technological advancements. For more information about the Open Solar initiative, please contact opensolar@uni-solar.com.

About United Solar/UNI-SOLAR®

United Solar has been a global leader in building-integrated and rooftop photovoltaics for over 25 years. The company manufactures, sells and installs thin-film solar laminates that convert sunlight into clean, renewable energy using proprietary technology for which the company has been awarded over 70 U.S. patents. UNI-SOLAR® brand products are unique because of their flexibility, light weight, ease of installation, durability, and real-world energy production. The company also designs, manufactures and installs rooftop photovoltaic systems, which enable customers to transform unused rooftop space into a value-generating asset. With the Open Solar™ initiative the company is seeking to build a community of solar innovators who will commercialize new products using the underlying, patented UNI-SOLAR technology. For more information on United Solar visit uni-solar.com or follow UNI-SOLAR on Facebook.com/unisolar and Twitter.com/uni_solar.

About SolarFocus Technology Co., Ltd.

Since 2005, SolarFocus has been at the forefront of the renewable energy revolution by providing competitively priced, energy saving and environmental-friendly solar powered products to both industry and consumers. As an industry leader in solar research and innovative product development, SolarFocus holds several solar technology patents with their products routinely used in such extreme environments as the Himalayas and the North Pole. For further information on SolarFocus products, please visit www.solarmio.com.

CONTACT: United Solar Contact:
         Kim Paulson
         Corporate Marketing Manager
         pr@uni-solar.com
         +1 (248) 299-6081

         SolarFocus Contact:
         Amy Chueh
         Sales Manager
         pr@solarmio.com
         +866-6615-8625

MGT Capital Investments (MGT) Names Robert Ladd as President and Chief Executive Officer

MGT Capital Investments, Inc. (“MGT,” “We,” or “the Company”) (AMEX: MGT – News), a holding company with operations in the healthcare industry, today announced that Robert Ladd has been named President and Chief Executive Officer, effective January 9, 2012. Mr. Ladd had previously served as interim President and Chief Executive Officer of the Company.

“We believe that we have made significant progress in 2011 by simplifying and rationalizing MGT and its subsidiaries. With consolidated cash of approximately $3.7 million at year-end 2011, and no debt, we believe that the Company is well-positioned to implement the necessary acquisition and divestiture strategies to support growth and investment returns for our shareholders. As the largest stockholder of MGT, I am excited to lead this transformation,” stated Robert Ladd, President and Chief Executive Officer.

About MGT Capital Investments, Inc.

MGT is a holding company comprised of MGT, the parent company, and its wholly-owned subsidiary MGT Capital Investments (U.K.) Limited. In addition we also have a controlling interest in our subsidiary, Medicsight Ltd, including its wholly owned subsidiaries.

Medicsight is a medical technology company with operations in medical imaging software development and medical hardware devices. The company provides a computer-aided detection software application that is used to assist radiologists with early detection and measurement of colorectal polyps. The Company’s software received a CE Mark in 2009, as well as clearance from the U. S. FDA in May 2011. Medicsight has also developed an automated carbon dioxide medical inflation device and associated disposable tubing (MedicCO 2 LON) that is being commercialized in partnership with a global distributor.

Forward Looking Statements

This press release contains forward-looking statements. The words or phrases “would be,” “will allow,” “intends to,” “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimate,” “project,” or similar expressions are intended to identify “forward-looking statements.” MGT’s financial and operational results reflected above should not be construed by any means as representative of the current or future value of its common stock. All information set forth in this news release, except historical and factual information, represents forward-looking statements. This includes all statements about the Company’s plans, beliefs, estimates and expectations. These statements are based on current estimates and projections, which involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These risks and uncertainties include issues related to: rapidly changing technology and evolving standards in the industries in which the Company and its subsidiaries operate; the ability to obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new business, license and sign new agreements; the unpredictable nature of consumer preferences; and other factors set forth in the Company’s most recently filed annual report and registration statement. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the risks and uncertainties described in other documents that the Company files from time to time with the U.S. Securities and Exchange Commission.

China Shen Zhou Mining & Resources (SHZ) Enters into Memorandum of Understanding

BEIJING, Jan. 9, 2012 /PRNewswire-Asia-FirstCall/ — China Shen Zhou Mining & Resources, Inc. (NYSE AMEX: SHZ), (“China Shen Zhou” or the “Company”), a Company engaged in the exploration, development, mining and processing of fluorite, zinc, lead, copper, and other nonferrous metals in China, today announced that the Company signed a Memorandum of Understanding to merge and acquire a number of fluorite and barite mining and mineral processing companies located in the Wuling mountains in the province of Guizhou. Negotiations are expected to be finalized within the next 60 days.

Since 2010, the Chinese government has issued a number of policies designed to raise the barriers to entry for the fluorite mining industry and to encourage fluorite mining companies to merge and integrate. China Shen Zhou, as the largest fluorite mining and mineral processing company in northern China, views the acquisition and integration of high-quality fluorite resources as a key part of the Company’s strategic plan.

Since the Company acquired 55% of Xinyi Mining Company in Anhui province, China Shen Zhou has considered acquiring a number of fluorite and barite rich mining companies located in southwestern China. As a result, China Shen Zhou identified and finished its due diligence on several targeted companies and the parties have reached an initial agreement regarding purchase price and transaction structure. Additional details concerning the acquisitions will be disclosed once the definitive agreements are executed.

Ms. Xiaojing Yu, the CEO of the China Shen Zhou, commented: “The Company has always believed that fluorite, as a widely used yet scarce strategic resource, will be in high demand given continuing economic development in China. China’s Wuling mountains are very rich in resources of fluorite and barite and possess excellent ore quality with low levels of phosphorus and sulfur. Barite is similar to fluorite as it is also a widely used diminishing resource.

“Because of China Shen Zhou’s advanced knowledge of the methods of separation of fluorite and barite ore and of methods of deep-processing of barite, the acquisitions of the Wuling mountain fluorite and barite resources will greatly enhance the Company’s reserves, laying the foundation for China Shen Zhou to become one of the largest fluorite mining and processing companies in China. Meanwhile, we will use the acquired barite resources to greatly improve the Company’s mining, processing and production capabilities.

“Furthermore, China Shen Zhou plans to work with local governments as well as both upstream and downstream enterprises to build a high-quality processing center and chemical industrial base to produce low-phosphorus and low-sulfur fluorite.”

Barite

Barite is a mineral consisting of barium sulfate, with a chemical composition of BaSO4, and is the largest natural mineral containing barium. Also, it is the largest source of barium. China is rich in barite, with barite reserves and production ranked the first in the world. Barite mines in China are mostly located in Guizhou province, which contains 34% of the total barite reserves in China.

Barite powder, the primary product of barite, is mainly used in the oil and gas industry as a weighting agent. Deep-processed precipitated barium sulfate, the raw material for making barium salts, is widely used in coatings, paints, inks, daily chemical products, textiles, papers and other products. Barite is categorized as a protective, non-metallic mining mineral by the Chinese Ministry of Land.

About China Shen Zhou Mining & Resources, Inc.

China Shen Zhou Mining & Resources, Inc., through its subsidiaries, is engaged in the exploration, development, mining, and processing of fluorite and nonferrous metals such as zinc, lead and copper in China. The Company has the following principal areas of interest in China: (a) fluorite extraction and processing in the Sumochaganaobao region of Inner Mongolia; (b) fluorite extraction and processing in Jingde County, Anhui Province; (c) zinc/copper/lead processing in Wulatehouqi of Inner Mongolia; and (d) zinc/copper exploration, mining and processing in Xinjiang.

For more information, please visit http://www.chinaszmg.com/.

Safe Harbor Statement

This press release may include certain statements that are not descriptions of historical facts, but are forward-looking statements. Forward-looking statements can be identified by the use of forward-looking terminology such as “will”, “believes”, “expects” or similar expressions. These forward-looking statements may also include statements about our proposed discussions related to our business or growth strategy, which is subject to change. Such information is based upon expectations of our management that were reasonable when made but may prove to be incorrect. All of such assumptions are inherently subject to uncertainties and contingencies beyond our control and upon assumptions with respect to future business decisions, which are subject to change. We do not undertake to update the forward-looking statements contained in this press release. For a description of the risks and uncertainties that may cause actual results to differ from the forward-looking statements contained in this press release, see our most recent Annual Report filed with the Securities and Exchange Commission (SEC) on Form 10-K, and our subsequent SEC filings. Copies of filings made with the SEC are available through the SEC’s electronic data gathering analysis retrieval system (EDGAR) at http://www.sec.gov.

Sprint Selects Mobile Network Director from Smith Micro Software (SMSI) to Help Optimize Network Experience for Users

Smith Micro Software, Inc. (NASDAQ: SMSI), a leading provider of wireless and mobility solutions, today announced that Sprint has selected Mobile Network Director™ to provide traffic management between networks (3G/4G /WiFi) while maintaining a high-quality experience for its subscribers.

Mobile Network Director helps Sprint meet today’s unprecedented growth in mobile data services. The precise, intelligent device controls provided by the solution can selectively manage data traffic in targeted locations during peak traffic periods. Mobile Network Director provides Sprint the ability to adjust network selection on subscribers’ devices as they move between coverage areas, enabling automated and seamless transitions between networks. Battery life on devices is increased since Mobile Network Director can turn on and off device radios as needed.

“While the majority of mobile operators have switched smartphone users to tiered data plans, Sprint is committed to offering our customers the best unlimited data plan in the industry,” said Fared Adib, Vice President of Product Development for Sprint. “Our relationship with Smith Micro Software is instrumental in the execution of that strategy, helping us to optimize our network resources while ensuring the best possible user experience. We’re looking forward to rolling out Mobile Network Director.”

“Improving the customer experience is the motivating force behind Sprint’s choice of our new solution,” said William W. Smith, Jr., President and CEO at Smith Micro Software. “We are excited to provide Sprint with a solution that automatically selects the best network option for the customer. Mobile Network Director makes the use of WiFi much simpler, which is a great convenience for the customer at home and in office environments. Testing has proven that WiFi management can actually improve battery performance as well.”

Sprint conducted extensive end users trials to evaluate the impact of using Mobile Network Director with customers utilizing multiple networks. The analytics proved that Sprint could improve the customer’s network experience through this unique approach and the trial results have been very positive.

For more information about Mobile Network Director, please visit www.smithmicro.com.

About Smith Micro Software, Inc.:

Smith Micro Software, Inc. provides software solutions that simplify, secure and enhance the mobile experience. Our portfolio of products and services spans Connectivity Management and Communications solutions. Smith Micro’s solutions include client and server software applications used by the world’s leading wireless operators, device manufacturers and enterprises. For more information about Smith Micro Software (NASDAQ: SMSI), visit smithmicro.com.

Safe Harbor Statement:

This release contains forward-looking statements that involve risks and uncertainties, including without limitation forward-looking statements relating to the company’s quarterly revenues guidance, its financial prospects and other projections of its performance, the company’s ability to increase its business and the anticipated timing and financial performance of its new products and services and potential acquisitions. Among the important factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements are changes in demand for the company’s products from its customers and their end-users, new and changing technologies and mobile communications products, customer acceptance of those technologies and products, new and continuing adverse economic conditions, and the company’s ability to compete effectively with other software providers. These and other factors discussed in the company’s filings with the Securities and Exchange Commission, including its filings on Forms 10-K and 10-Q, could cause actual results to differ materially from those expressed or implied in any forward-looking statements. The forward-looking statements contained in this release are made on the basis of the views and assumptions of management regarding future events and business performance as of the date of this release, and the company does not undertake any obligation to update these statements to reflect events or circumstances occurring after the date of this release.

Smith Micro, Mobile Network Director, and the Smith Micro logo are registered trademarks or trademarks of Smith Micro Software, Inc. All other trademarks and product names are the property of their respective companies.

Aviat Networks (AVNW) Reaffirms Revenue Guidance

Lantronix (LTRX) Demonstrates Easy Plug-and-Print Solution for iPad and Apple iOS Devices at Digital Experience 2012

LAS VEGAS, NV — (Marketwire) — 01/09/12 — Lantronix, Inc. (NASDAQ: LTRX), a leading global provider of smart connectivity solutions, today announced it is showcasing its new xPrintServer™ at Digital Experience on January 9, 2012, the evening prior to the 2012 International CES in Las Vegas. With more than 900 editors and members of the press in attendance, Digital Experience is the nation’s largest technology media event.

The xPrintServer is the first Apple iOS® print server compatible with the iPad®2, iPad, iPhone®, iPod® touch, and virtually any device running Apple’s iOS mobile operating system. Lantronix will provide the first live public demonstration of the xPrintServer in action — enabling iPad and other iOS users to print directly from their iOS devices during the event.

“We are very pleased to see the positive response from the market on our xPrintServer,” said Kurt Busch, president and CEO for Lantronix. “It’s clear we are filling a much needed gap in the Apple ecosystem, and we look forward to the first live demonstration at Digital Experience.”

The xPrintServer, roughly the size of an iPhone, is an easy-to-use hardware solution that utilizes the iOS native print menu and requires no additional applications, software downloads, or printer driver installations. With automatic printer discovery and no configuration, printing is easy and hassle-free. Simply open the box, plug the xPrintServer anywhere into the network, and print wirelessly from any iOS device running iOS version 4.2 or later, to virtually any network-connected printer.

The xPrintServer currently supports thousands of networked printer models from leading printer families including HP, Brother, Epson, Canon, Dell, Lexmark, and Xerox. As new printer brands and printer models become available, Lantronix will post updates on www.Lantronix.com.

How to Buy
The xPrintServer, which is currently available for pre-ordering at www.Lantronix.com, is scheduled to begin shipping in the first calendar quarter of 2012, at which time it will also be available on Amazon, NewEgg, Buy.com, and MacMall websites. As the first product in the xPrintServer family, the xPrintServer-Network Edition retails for $149.95 MSRP, and is designed for enterprises and consumers using network-connected printers, either wired or wireless.

About Lantronix
Lantronix, Inc. (NASDAQ: LTRX) is a global leader of secure communication technologies that simplify access and communication with and between virtually any electronic device. Our smart connectivity solutions enable sharing data between devices and applications to empower businesses to make better decisions based on real-time information, and gain a competitive advantage by generating new revenue streams, improving productivity and increasing efficiency and profitability. Easy to integrate and deploy, Lantronix products remotely and securely connect electronic equipment via networks and the Internet. Founded in 1989, Lantronix serves some of the largest medical, security, industrial and building automation, transportation, retail/POS, financial, government, consumer electronics/appliances, IT/data center and pro-AV/signage entities in the world. The company’s headquarters are located in Irvine, Calif.

For more information, visit www.lantronix.com. The Lantronix blog, http://www.lantronix.com/blog, features industry discussion and updates.

Watch our xPrintServer launch video today! To follow Lantronix on Twitter, visit http://www.twitter.com/Lantronix.

© 2012 Lantronix, Inc. Lantronix, Inc. and Lantronix are registered trademarks, and xPrintServer is a trademark of Lantronix, Inc. iPad, iPhone, iPod, iPod classic, iPod nano, and iPod touch are trademarks of Apple, Inc., registered in the U.S. and other countries. All other trademarks and trade names are the property of their respective holders. Specifications subject to change without notice. All rights reserved.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1847875

Add to Digg Bookmark with del.icio.us Add to Newsvine

Media Contacts:
Christine Cabori
Lages & Associates, Inc.
Email Contact
949.453.8080

Beverly Lages
Lages & Associates, Inc.
Email Contact
949.453.8080

Pansoft (PSOF) Receives Offer from Timesway Group to Acquire Remaining Outstanding Shares

Cardium (CXM) Regains Listing Compliance With NYSE Amex

AdCare Health Systems (ADK) to Acquire Three Skilled Nursing Facilities in Arkansas

SPRINGFIELD, OH — (Marketwire) — 01/06/12 — AdCare Health Systems, Inc. (NYSE Amex: ADK), a leading nursing home and assisted living company, has signed a definitive purchase agreement for three skilled nursing facilities in Arkansas for $27.3 million.

The facilities have an aggregate of 439 beds and generate an estimated $22.2 million in gross annualized revenues according to their most recent financials. The acquisition is anticipated to be completed in the first quarter of 2012. AdCare plans to finance the acquisition of the facilities with a traditional bank loan.

Combining the company’s current annualized run-rate with transactions in the process of closing, AdCare’s estimated annualized revenue run-rate is expected to exceed $322 million. This would represent an increase of more than 500% over the company’s revenues in 2010, and an increase of more than 12 times revenues since initiating its M&A campaign in the fall of 2009.

“Included in this portfolio is a 157 bed skilled nursing facility located in close proximity to a major Little Rock acute-care hospital,” said Boyd Gentry, AdCare’s president and chief executive officer. “This facility has recently been completely renovated, which allows us to reposition it as a major provider of sub-acute services. We expect this strategy to generate a significant increase in revenues as we improve this facility’s occupancy with higher acuity patients. The other two facilities are ideally configured with a significant number of private rooms.”

According to Chris Brogdon, AdCare’s vice chairman and chief acquisitions officer: “This signing brings the total number of facilities we’ve put under contract to 54 since we began our current M&A program. With our M&A program and the integration of new facilities remaining our major focus in 2012, we continue to evaluate a number of opportunities that fit our acquisition strategy.”

Gentry added: “We have been targeting facilities in the Midwest and Southern states that have not traditionally concentrated on providing post-acute services. Then, once acquired, we have worked to increase Medicare census and occupancy, as well as optimize reimbursement and patient care. This strategy continues to yield results, as our team has been successful at increasing both higher acuity patients and associated reimbursement rates in excess of 25% versus pre-acquisition levels.”

AdCare expects to complete the acquisition of at least 23 additional facilities in the first quarter of 2012: the three announced today, five facilities in Oklahoma and the company’s largest transaction to-date of 15 facilities across the Southeast.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Important Cautions Regarding Forward-Looking Statements
Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of federal law. Such statements can be identified by the use of forward-looking terminology, such as “believes,” “expects,” “plans,” “intends,” “anticipates” and variations of such words or similar expressions, but their absence does not mean that the statement is not forward-looking. Statements in this announcement that are forward-looking include, but are not limited to, statements about the company’s expected annualized revenue run-rate and statements regarding the signing and expected closing of transactions, as well as statements regarding transactions being accretive to the company’s earnings. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management, and involve known and unknown risks, results, performance or achievements of AdCare which may differ materially from those expressed or implied in such statements. Such factors are identified in the public filings made by AdCare with the Securities and Exchange Commission and include, among others, AdCare’s ability to secure lines of credit and/or an acquisition credit facility, find suitable acquisition properties at favorable terms, changes in the health care industry because of political and economic influences, changes in regulations governing the industry, changes in reimbursement levels including those under the Medicare and Medicaid programs and changes in the competitive marketplace. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements. Except where required by law, AdCare undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Company Contacts
Boyd Gentry, CEO
Chris Brogdon, Vice Chairman & CAO
David A. Tenwick, Chairman of Board
AdCare Health Systems, Inc.
Tel (937) 964-8974

Investor Relations
Ron Both or Geoffrey Plank
Liolios Group, Inc.
Tel (949) 574-3860

Jingwei International Ltd. (JNGW) Announces Receipt of “Go Private” Proposal

SHENZHEN, China, Jan. 6, 2012 /PRNewswire-Asia-FirstCall/ — Jingwei International Limited (NASDAQ: JNGW) (“Jingwei” or “the Company”), a leading provider of data-mining, interactive marketing and software services in China, today announced it has received a proposal from George (Jianguo) Du, Chairman and CEO of the Company, for a “going private” transaction designed to eliminate Jingwei’s status as a public company in the U.S..

Mr. Du owns 41.1% of Jingwei’s common shares. According to the proposal letter, he would ask the Board of Directors to consider a reverse stock split transaction that would include a reverse split at a 1-for-50,000 share ratio followed by a cancellation of all fractional shares below one whole share at a per share price of $1.56. To the extent necessary to finance the proposed transaction, he is willing to provide funding to Jingwei at a price of $1.56 per share to fund the cancellation of fractional shares following a reverse split in order to effect the going-private transaction, which would be financed solely through available personal funds.

The board of directors cautions Jingwei’s shareholders and others considering trading in its securities that it has only received the proposal and that no decisions have been made by the board of directors with respect to the Company’s response to the proposal. There can be no assurance that any definitive offer will be made, that any agreement will be executed or that this or any other transaction will be approved or consummated. The board of directors has formed a special committee of independent directors to consider the proposal. The committee has retained independent financial advisors to assist it in its work.

About Jingwei International Limited:

Jingwei International Limited (“Jingwei”) has established a leading position in China in data mining, interactive marketing and software services. To capitalize on China’s rapid growth on mobile, Internet and e-Commerce applications, Jingwei has focused on new data mining offerings that encompass interactive marketing, bundled mobility solutions and mobile value added services. The Company’s software services include business intelligence, billing, customer relationship management and decision support solutions for Chinese telecom operators and power companies.

Business Risks and Forward-Looking Statements

This report includes forward-looking statements. Generally, the words “believes,” “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.

PLC Systems (PLCSF) to Present at OneMedForum in San Francisco

Endo Pharmaceuticals (ENDP) and BioDelivery Sciences International (BDSI) Sign Licensing Agreement

Cardium (CXM) Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea

A123 Systems (AONE) to Supply Advanced Lithium Ion Battery Packs to VIA Motors for Extended-Range Electric Trucks

WALTHAM, Mass., Jan. 5, 2012 (GLOBE NEWSWIRE) — A123 Systems (Nasdaq:AONE), a developer and manufacturer of advanced Nanophosphate®lithium ion batteries and systems, today announced that it will supply complete lithium ion battery packs to VIA Motors, an electric vehicle company building next-generation electrified trucks, vans and SUVs. To be integrated into VIA’s Extended-Range Electric Vehicle (eREV) Powertrain, A123’s 24kWh battery packs combine with a 300kW electric motor and an onboard generator to deliver an expected all-electric driving range of up to 40 miles.

“VIA plans to ramp up production significantly over the next three years to satisfy demand for clean, fuel-efficient full-size trucks and SUVs,” said Kraig Higginson, CEO of VIA Motors. “We selected A123’s Nanophosphate lithium ion battery systems because they are able to package higher power into a compact space in the vehicle.”

VIA offers a full lineup of extended-range electric trucks, vans and SUVs called VTRUX, each equipped with the company’s eREV Powertrain. In addition to supporting an expected all-electric range of about 40 miles, A123’s lithium ion battery systems are also designed to provide exportable power capabilities that can be used externally. A123 has already begun producing the battery packs at its Livonia, Mich. facility as VIA has started delivering trucks to commercial fleet customers.

“We believe that the high power, greater usable energy and long life offered by our Nanophosphate lithium ion battery solutions will help VIA better position its eREV Powertrain platform as a cost-effective solution to maximize vehicle range and increase fuel economy,” said Jason Forcier, vice president of A123’s Automotive Solutions Group. “We think that commercial and government fleets represent a tremendous opportunity for vehicle electrification, and we look forward to working with VIA Motors to design eREV trucks, vans and SUVs that meet fleet customers’ needs for efficient, environmentally friendly vehicles that also satisfy their performance, range and reliability requirements.”

About A123 Systems

A123 Systems, Inc. (Nasdaq:AONE) is a leading developer and manufacturer of advanced lithium-ion batteries and energy storage systems for transportation, electric grid and commercial applications. The company’s proprietary Nanophosphate® technology is built on novel nanoscale materials initially developed at the Massachusetts Institute of Technology and is designed to deliver high power and energy density, increased safety and extended life. A123 leverages breakthrough technology, high-quality manufacturing and expert systems integration capabilities to deliver innovative solutions that enable customers to bring next-generation products to market. For additional information please visit www.a123systems.com.

The A123 Systems, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6600

Safe Harbor Disclosure

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including statements with respect to including statements with respect to the expected production and availability of VIA’s Extended-Range Electric Vehicle (eREV), and its anticipated performance, benefits and features, as well as the expected demand by VIA for battery packs to be supplied by A123, the expected performance of such battery packs and their ability to meet the eREV’s requirements, and the market for alternative-energy transportation in commercial vehicle fleet and consumer transportation applications. Among the factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: delays in customer and market demand for and adoption of VIA’s eREV, delays in the development, production and supply of A123’s battery packs, adverse economic conditions in general and adverse economic conditions specifically affecting the markets in which A123 and VIA operate and other risks detailed in A123 Systems’ 10-Q for the quarter ended September 30, 2011 and other publicly available filings with the Securities and Exchange Commission. All forward-looking statements reflect A123’s expectations only as of the date of this release and should not be relied upon as reflecting A123’s views, expectations or beliefs at any date subsequent to the date of this release.

CONTACT: A123 Systems PR Contact:
         A123 Systems
         Dan Borgasano
         617-972-3471
         dborgasano@a123systems.com

         A123 Systems IR Contact:
         ICR, LLC
         Garo Toomajanian
         617-956-6725
         ir@a123systems.com

         Edelman
         Courtney Kessler
         212-277-3720
         courtney.kessler@edelman.com

Magyar Bank (MGYR) Sells $6.3 Million in Real Estate Owned During 2011

NEW BRUNSWICK, N.J., Jan. 5, 2012 /PRNewswire/ — Magyar Bank, the principal subsidiary of Magyar Bancorp, Inc., announced today that in calendar year 2011, the Bank disposed of 9 properties with a carrying value of $6.3 million that were previously held by the Bank as Other Real Estate Owned. Included in this total are 2 properties with a carrying value of $3.2 million which were sold during the Company’s First Quarter of Fiscal Year 2012.

John Fitzgerald, President and Chief Executive Officer of Magyar Bancorp stated, “The sale of these properties is further confirmation that our strategy in addressing non-performing assets is working. In New Jersey, it is not uncommon for the foreclosure process to take 3 years before the Bank can gain control of the property and begin actively selling it. However, our aggressive approach has allowed the Bank to gain control of and dispose of certain properties in a quicker fashion.”

Mr. Fitzgerald added, “We expect this positive momentum in resolution of credit issues to continue in 2012. We currently have contracts of sale for additional properties which we expect to close during this calendar year.”

About Magyar Bancorp
Magyar Bancorp is the parent company of Magyar Bank, a community bank headquartered in New Brunswick, New Jersey. Magyar Bank has been serving families and businesses in Central New Jersey since 1922 with a complete line of financial products and services. Today, Magyar operates six branch locations in Edison, New Brunswick, North Brunswick, South Brunswick, Branchburg and Bridgewater. Please visit us online at www.magbank.com.

Forward Looking Statements
This press release contains statements about future events that constitute forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements may be identified by reference to a future period or periods, or by the use of forward- looking terminology, such as “may,” “will,” “believe,” “expect,” or similar terms or variations on those terms, or the negative of those terms. Forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, those risks previously disclosed in the Company’s filings with the SEC, and with respect to the loans extended by the Bank and real estate owned, the following: risks related to the economic environment in the market areas in which the Bank operates, particularly with respect to the real estate market in New Jersey; the risk that the value of the real estate securing these loans may decline in value; and the risk that significant expense may be incurred by the Company in connection with the resolution of these loans. The Company wishes to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The Company does not undertake and specifically declines any obligation to publicly release the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

Frederick’s of Hollywood (FOH) Announces a 6.3% Increase in December Comparable Store Sales

HOLLYWOOD, Calif., Jan. 5, 2012 /PRNewswire/ — Frederick’s of Hollywood Group Inc. (NYSE Amex: FOH) (“Company”) announced today that its comparable store sales for the five weeks ended December 31, 2011 increased 6.3% compared to the five weeks ended January 1, 2011. The Company also announced a comparable store sales increase of 5.3% for the 22 weeks ended December 31, 2011, compared to the 22 weeks ended January 1, 2011.

“The 2012 Holiday season was topped off by strong comparable store sales and healthy store margins for the December period. It is exciting to see many of the improvements made to drive sales for our retail stores, including our new product line introduced in mid-2011, continued to gain traction throughout the holiday period,” stated Thomas Lynch, the Company’s Chairman and Chief Executive Officer.

Forward Looking Statement
Certain of the matters set forth in this press release are forward-looking and involve a number of risks and uncertainties. These statements are based on management’s current expectations or beliefs. Actual results may vary materially from those expressed or implied by the statements herein. Among the factors that could cause actual results to differ materially are the following: competition; business conditions and industry growth; rapidly changing consumer preferences and trends; general economic conditions; working capital needs; continued compliance with government regulations; loss of key personnel; labor practices; product development; management of growth, increases in costs of operations or inability to meet efficiency or cost reduction objectives; timing of orders and deliveries of products; risks of doing business abroad; the ability to protect our intellectual property; and the other risks that are described from time to time in the Company’s SEC reports. The Company is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise.

About Frederick’s of Hollywood Group Inc.
Frederick’s of Hollywood Group Inc., through its subsidiaries, sells women’s intimate apparel, swimwear and related products under its proprietary Frederick’s of Hollywood^® brand through 123 specialty retail stores, a world-famous catalog and an online shop at http://www.fredericks.com/. With its exclusive product offerings including Seduction by Frederick’s of Hollywood and the Hollywood Exxtreme Cleavage^® bra, Frederick’s of Hollywood is the Original Sex Symbol^®.

Our press releases and financial reports can be accessed on our corporate website at http://www.fohgroup.com.

This release is available on the KCSA Strategic Communications Web site at http://www.kcsa.com.

CONTACT:
Frederick’s of Hollywood Group Inc.
Thomas Rende, CFO
(212) 779-8300

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
212-896-1215 / 212-896-1250
tfromer@kcsa.com / grussell@kcsa.com

NEI (NEI) Announces Improved Outlook for First Fiscal Quarter

CANTON, Mass., Jan. 5, 2012 /PRNewswire/ — NEI (Nasdaq: NEI), a leading provider of server-based application platforms, deployment solutions and lifecycle support services for software technology developers and OEMs worldwide, today provided revised and improved expectations for the first fiscal quarter, the period ended December 31, 2011.

Based upon preliminary estimates for the fiscal first quarter, management now expects:

• Net revenues in the range of $68 million to $70 million, greater than the original guidance of $58 million to $63 million provided on November 10, 2011.
• Net income on a GAAP basis in the range of $1.3 million to $1.6 million, compared to prior guidance of GAAP net income of $500,000 to $1.0 million.

Greg Shortell, President and Chief Executive Officer of NEI, commented, “In providing our December quarter guidance, we expected an impact of between $4.0 million and $5.0 million of revenues related to the unavailability of hard disk drives due to supply constraints tied to the Thailand flooding. Based on the extraordinary efforts of our supply chain team and our vendors, we were able to secure drives needed to realize most of these revenues. Additionally, some of our customers exceeded the volume estimates that we had projected for the December quarter, resulting in higher revenues. Our review of the quarter’s financial results is ongoing, and we will provide more detail on our conference call at the end of January.”

NEI expects to announce its financial results on or about January 26, 2012, at which time management will hold a conference call to discuss the Company’s operating performance and financial outlook for the second fiscal quarter.

About NEI

NEI is a leading provider of server-based application platforms and lifecycle support services for software developers and OEMs worldwide. Through its expertise and comprehensive suite of solution design, system integration, application management, global logistics, support, and maintenance services, NEI is redefining application deployment solutions to provide customers with a sustainable competitive advantage. More than a decade of appliance innovation with the ability to provide physical, virtual and cloud-ready solutions makes NEI one of the most trusted software deployment partners in the industry. Founded in 1997, NEI is headquartered in Canton, Massachusetts, with facilities in Plano, Texas and Galway, Ireland, and trades on the NASDAQ exchange under the symbol NEI. For more information, visit www.nei.com.

Safe Harbor for Forward-Looking Statements

Statements in this press release regarding the Company’s future financial performance, including statements regarding net revenues, net income and any other statements about the Company’s management’s future expectations, beliefs, goals, plans or prospects, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including those factors contained in the Company’s most recent Annual Report on Form 10-K for the year ended September 30, 2011 under the section “Risk Factors” as well as other documents that may be filed by the Company from time to time with the Securities and Exchange Commission. Forward-looking statements include statements regarding the Company’s expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will,” and “would” or similar words. The Company assumes no obligations to update the information included in this press release.

CONTACT: Peter Seltzberg of Hayden IR, 646-415-8972

AdCare Health (ADK) Completes Acquisition of Skilled Nursing and Assisted Living Center in Ohio

SPRINGFIELD, OH — (Marketwire) — 01/03/12 — AdCare Health Systems, Inc. (NYSE Amex: ADK), a leading nursing home and assisted living company, has completed the previously announced agreement to purchase a skilled nursing and assisted living community in Ohio. The final purchase price was $12.5 million — $1.0 million less than the initial purchase agreement — with the effective closing date of December 30, 2011.

The community has 179 beds in service and generates an estimated $12 million in gross annualized revenues according to its most recent financials. Its addition is expected to be immediately accretive to AdCare’s earnings.

AdCare will finance the acquisition of the assisted living facility with a 30-year, fixed-rate, tax-exempt bond issuance, and financed the skilled nursing facility with a traditional bank loan.

This transaction brings the total number of facilities AdCare’s purchased, leased, or managed to 44 facilities since its M&A campaign began in the fall of 2009, representing more than 3,900 beds in service.

The company plans to continue pursuing an aggressive M&A program. Combining its current annualized run-rate with transactions in the process of closing, AdCare’s estimated annualized revenue run-rate is expected to exceed $300 million. This would represent an increase of more than 460% over the company’s revenues in 2010, and an increase of more than 11 times revenues since initiating its M&A campaign in the fall of 2009.

“After expanding our operations to Alabama, Arkansas, Georgia, North Carolina and Oklahoma, with this acquisition we’ve built upon our home base in Ohio,” noted Chris Brogdon, AdCare’s vice chairman and chief acquisitions officer. “These new facilities will leverage the professional support staff we’ve long maintained in the state, as well as enhance our overall economies of scale.”

“We’re continuing to evaluate a number of attractive opportunities in the Midwest, as well as in the Southwest and Southeast,” added Brogdon, “with our M&A program and the integration of new facilities remaining our primary focus going forward.”

According to Boyd P. Gentry, AdCare’s president and chief executive officer: “Our strategy of acquiring skilled nursing facilities is proving highly successful, not only in our closing rate and terms, but especially in our post-acquisition performance. We have been targeting facilities that have not traditionally concentrated on providing post-acute services, and then once acquired, we increase Medicare census and occupancy, as well as optimize reimbursement and patient care.”

“Historically, it takes our operations team a year to 15 months to fully harvest this opportunity in an individual facility,” continued Boyd. “This means we still have optimization opportunities in our current portfolio, and significant upside exists in our pending acquisition pipeline.”

AdCare finishes 2011 having placed 29 new facilities under contract during the year, with the acquisition of 18 facilities completed. As previously announced, AdCare expects to complete the acquisition of at least 20 more in the first quarter of 2012, including five facilities in Oklahoma and the company’s largest transaction to-date of 15 facilities across the Southeast.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Important Cautions Regarding Forward-Looking Statements
Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of federal law. Such statements can be identified by the use of forward-looking terminology, such as “believes,” “expects,” “plans,” “intends,” “anticipates” and variations of such words or similar expressions, but their absence does not mean that the statement is not forward-looking. Statements in this announcement that are forward-looking include, but are not limited to, statements about the company’s expected annualized revenue run-rate, as well as statements regarding transactions being accretive to the company’s earnings.. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management, and involve known and unknown risks, results, performance or achievements of AdCare which may differ materially from those expressed or implied in such statements. Such factors are identified in the public filings made by AdCare with the Securities and Exchange Commission and include, among others, AdCare’s ability to secure lines of credit and/or an acquisition credit facility, find suitable acquisition properties at favorable terms, changes in the health care industry because of political and economic influences, changes in regulations governing the industry, changes in reimbursement levels including those under the Medicare and Medicaid programs and changes in the competitive marketplace. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements. Except where required by law, AdCare undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Company Contacts
Boyd Gentry, CEO
Chris Brogdon, Vice Chairman & CAO
David A. Tenwick, Chairman of Board
AdCare Health Systems, Inc.
Tel (937) 964-8974
Email Contact

Investor Relations
Ron Both or Geoffrey Plank
Liolios Group, Inc.
Tel (949) 574-3860
Email Contact

NeurogesX (NGSX) Appoints Ronald Martell President and Chief Executive Officer

SAN MATEO, Calif., Jan. 3, 2012 (GLOBE NEWSWIRE) — NeurogesX, Inc. (Nasdaq:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced that the Board of Directors has appointed Ronald A. Martell as President and Chief Executive Officer, and a member of the board. Mr. Martell brings over 30 years of experience in the biotechnology industry including direct commercialization experience.

Prior to joining NeurogesX, Mr. Martell was Chief Executive Officer at Poniard Pharmaceuticals, Inc., where he served for four years. Mr. Martell’s experience includes Imclone Systems, where over his tenure he held progressively more responsible positions, and led the successful launch and initial commercialization of oncology drug Erbitux and served as a member of the deal execution teams that led to major pharmaceutical partnerships. Earlier in his career, Mr. Martell was with Genentech and led the commercial launch of the company’s blockbuster oncology drugs, Rituxan and Herceptin, as well as the development of global marketing plans for the oncology product portfolio.

Gary Lyons, Executive Chairman of the board, stated, “The board has conducted a thorough and diligent process to identify the optimum candidate to lead NeurogesX at this pivotal time in its development. During the last quarter, we announced positive Phase 2 data for NGX-1998, our topical liquid formulation of high-concentration capsaicin, the restructuring of the Company’s sales force and the FDA acceptance of review of our sNDA for Qutenza (capsaicin) 8% patch for HIV-associated peripheral neuropathy, or HIV-PN.”

Mr. Lyons continued, “Ronald Martell brings the attributes and track record that meet the leadership needs for a commercial company with two major near term product opportunities. His experience in launching and developing drugs will be invaluable to the team as we move forward. Commensurate with Ron’s appointment, long time President and CEO, Tony DiTonno retired as of December 31, 2011. On behalf of the board, we thank Tony for his leadership and dedication and wish him well in his new endeavors.”

Ronald Martell, President and CEO of NeurogesX, noted, “NeurogesX is an exciting opportunity as it is uniquely positioned with Qutenza approved for PHN and a potential label expansion in painful HIV-peripheral neuropathy. I am also very excited about our liquid formulation NGX-1998, which recently completed a successful Phase 2 clinical study demonstrating initial evidence of safety and efficacy, which I believe represents a very significant potential product opportunity. I look forward to advancing NeurogesX’ strategy as a world leading pain management biopharmaceutical company.”

About NeurogesX, Inc.

NeurogesX, Inc. (Nasdaq:NGSX) is a San Francisco Bay Area-based biopharmaceutical company focused on developing and commercializing novel pain management therapies. NeurogesX was founded on the concept that use of prescription-strength capsaicin could help manage the pain associated with neuropathic pain conditions. Since its inception, NeurogesX has leveraged its passion to help people with pain to efficiently develop this concept, resulting in the commercial launch of Qutenza (capsaicin) 8% patch in 2010. The Company continues to apply its knowledge and expertise in the development of other novel treatments for pain.

The Company’s lead product, Qutenza, is a localized dermal delivery system containing prescription strength capsaicin that is currently approved in the United States and the European Union. Qutenza is now available in the United States for the management of neuropathic pain associated with postherpetic neuralgia (PHN). In Europe, Qutenza is being marketed by Astellas Pharma Europe Ltd. (Astellas), the European affiliate of Tokyo-based Astellas Pharma Inc., for the treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain.

The Company has submitted a supplemental new drug application (sNDA) to expand the U.S. label for Qutenza for the management of pain due to HIV-associated peripheral neuropathy (HIV-PN) previously referred to as HIV-associated neuropathy (HIV-AN) and HIV-distal sensory polyneuropathy (HIV-DSP).

The Company’s most advanced product candidate, NGX-1998, is a topically applied liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions such as PHN. NGX-1998 has completed three Phase 1 clinical trials and one Phase 2 clinical trial in PHN patients.

The Company’s early-stage pipeline includes pre-clinical compounds which include a number of prodrugs of acetaminophen. The Company has evaluated certain of these compounds in vitro and in vivo.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the Act). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include but are not limited to statements regarding: the potential expansion of the U.S. label for Qutenza to include management of pain due to HIV-associated peripheral neuropathy (HIV-PN); and expectations regarding NGX-1998 as a very significant potential product opportunity if approved by the FDA. Such statements are based on management’s current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to: difficulties or delays in the further development of Qutenza for additional indications, including difficulties or delays in receipt of FDA approval of the sNDA to expand the U.S. label for Qutenza for the management of pain due to HIV-PN; market acceptance of Qutenza in already approved indications may not be sufficient to support further pursuit of an expanded label for Qutenza; Qutenza, NGX-1998 and NeurogesX’ other product candidates may have unexpected adverse side effects; and NGX-1998 may fail to demonstrate sufficient safety or efficacy in clinical trials to support further development or potential marketing approval. For further information regarding these and other risks related to NeurogesX’ business, investors should consult NeurogesX’ filings with the Securities and Exchange Commission.

CONTACT: NeurogesX, Inc.
         Stephen Ghiglieri
         Executive Vice President, COO
         and CFO
         (650) 358-3310
         sghiglieri@neurogesx.com

         The Ruth Group
         Stephanie Carrington (investors)
         (646) 536-7017
         scarrington@theruthgroup.com

         Victoria Aguiar (media)
         (646) 536-7013
         vaguiar@theruthgroup.com

Sonde Resources Corp. (SOQ) Announces Redemption of Convertible Preferred Shares

CALGARY, ALBERTA — (Marketwire) — 01/03/12 — Sonde Resources Corp. (“Sonde” or the “Company”) (TSX:SOQ) (NYSE Amex:SOQ) announced today that it has redeemed all 150,000 of its previously outstanding US $100.00 5% Cumulative Redeemable Convertible Preferred Shares, Series B (the “Preferred Shares”). The Preferred Shares were redeemed at a price equal to US $100.00 for each Preferred Share, plus an amount equal to all accrued and unpaid dividends per Preferred Share to December 30, 2011, being US $1.25 per Preferred Share. Sonde used existing cash balances to fund the redemption of the Preferred Shares, which totaled US $15,186,987.

Sonde Resources Corp. is a Calgary, Alberta, Canada based energy company engaged in the exploration and production of oil and natural gas. Its operations are located in Western Canada and offshore North Africa. See Sonde’s website at www.sonderesources.com to review further detail on Sonde’s operations.

Contacts:
Sonde Resources Corp.
Investor Relations
(403) 294-1411
(403) 216-2374 (FAX)

Sonde Resources Corp.
Suite 3200, 500 – 4th Avenue S.W.
Calgary, Alberta, Canada T2P 2V6
www.sonderesources.com

XOMA (XOMA) Secures $10 Million Term Loan

BERKELEY, Calif., Jan. 3, 2012 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that it has entered into a $10.0 million 42-month secured term loan agreement with GE Capital, Healthcare Financial Services. The funds will be used for advancement of gevokizumab (XOMA 052), XOMA’s lead clinical product candidate, and for general corporate purposes. Interest on the loan is payable at 11.71% per annum. In addition, XOMA has issued warrants to the lender to purchase 263,158 shares of its common stock exercisable at $1.14 per share.

“The increase in cash position provided by this debt financing is part of our overall strategy to fund gevokizumab development and other programs toward potential value-creating milestones,” said Fred Kurland, XOMA’s Vice President and Chief Financial Officer.

About XOMA

XOMA is a leader in the discovery and development of novel antibody therapeutics. The company’s proprietary product pipeline includes:

• Gevokizumab (XOMA 052), a humanized antibody that binds to the inflammatory cytokine interleukin-1 beta, or IL-1 beta. XOMA plans to enter gevokizumab into Phase 3 clinical development in non-infectious uveitis affecting the intermediate and/or posterior segments of the eye, and has initiated a Phase 2 proof-of-concept trial for the treatment of moderate and severe acne vulgaris. Les Laboratoires Servier is XOMA’s development and commercialization partner for gevokizumab.
• A preclinical pipeline with candidates in development for autoimmune, cardio-metabolic, inflammatory and oncological diseases. Among these are two new classes of fully human monoclonal antibodies that activate (XMetA) or sensitize (XMetS) the insulin receptor in vivo, which represent distinct new therapeutic approaches to the treatment of patients with diabetes.
• Antibodies against botulinum toxins, led by XOMA 3AB, a novel combination of three antibodies to prevent and treat botulism poisoning caused by exposure to botulinum neurotoxin Type A, among the most deadly bioterror threats. XOMA 3AB is in a Phase 1 clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). Development of these antibodies has been funded in whole or in part with funds from NIAID, NIH, Department of Health and Human Services under Contract No. HHSN266200500004C, Contract No. HHSN266200600008C, Contract No. HHSN272200800028C, Contract No. HHSN266200600011C, Contract No., HHSN272200800026C, and Contract No. HHSN2722011031C.

XOMA has a premier antibody discovery and development platform that incorporates an unmatched collection of antibody phage display libraries and proprietary optimization and expression and manufacturing technologies that it uses for its own pipeline and in collaborations with pharmaceutical and biotechnology companies. XOMA’s fully integrated product development infrastructure extends from preclinical science to approval and is located in Berkeley, California. For more information, please visit www.xoma.com.

The XOMA Ltd. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5960

About GE Capital, Healthcare Financial Services

With in-depth industry knowledge and expertise, GE Capital, Healthcare Financial Services has provided more than $60 billion in financing over 10 years to companies in over 40 healthcare sub-sectors including senior housing, hospitals, medical offices, outpatient services, pharmaceuticals and medical devices. Our team of professionals creates business and financial solutions tailored to meet the individual needs of our customers. For more information, visit gecapital.com/healthcare.

Forward-Looking Statements

Certain statements contained herein concerning product development or that otherwise relate to future periods are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions that may not prove accurate. Actual results could differ materially from those anticipated due to certain risks inherent in the biotechnology industry and for companies engaged in the development of new products in a regulated market.

These risks, including those related to the generally unstable nature of current economic and financial market conditions; the results of discovery and pre-clinical testing; the timing or results of pending and future clinical trials (including the design and progress of clinical trials; safety and efficacy of the products being tested; action, inaction or delay by the FDA, European or other regulators or their advisory bodies; and analysis or interpretation by, or submission to, these entities or others of scientific data); changes in the status of existing collaborative or licensing relationships; the ability of collaborators, licensees and other third parties to meet their obligations and their discretion in decision-making; XOMA’s ability to meet the demands of the United States government agency with which it has entered into its government contracts; competition; market demand for products; scale-up, manufacturing and marketing capabilities; availability of additional licensing or collaboration opportunities; international operations; share price volatility; XOMA’s financing needs and opportunities; uncertainties regarding the status of biotechnology patents; uncertainties as to the costs of protecting intellectual property; and risks associated with XOMA’s status as a Bermuda company, are described in more detail in XOMA’s most recent filing on Form 10-K and in other SEC filings. Consider such risks carefully when considering XOMA’s prospects.

CONTACT: XOMA Corporation
         Company and Investor Contact:
         Carol DeGuzman
         510-204-7270
         deguzman@xoma.com

         Canale Communications
         Media Contact:
         Pam Lord
         619-849-6003
         pam@canalecomm.com

Susan Cochran Joins Capital Bank (CBKN) as Senior Commercial Portfolio Manager

TEGA CAY, S.C., Jan. 3, 2012 /PRNewswire/ –Capital Bank, N.A. (Nasdaq: CBKN) recently announced the appointment of Susan Cochran as Senior Commercial Portfolio Manager in Tega Cay, South Carolina. Cochran will serve the Commercial Banking division by completing spreads and renewals, assisting with new loan requests and by completing annual reviews for lenders in the Tega Cay & Charleston markets.

Cochran comes to Capital Bank with a bachelor’s degree in Business Administration with a concentration in Finance from Tennessee Technological University, and nearly 20 years of experience in the commercial lending industry where she has completed the credit analysis and underwriting on loans $2 million and above. “I’m excited to join the Stonecrest and Charleston teams and to have the opportunity to work with Capital Bank,” said Cochran. “I look forward to the growth 2012 has to bring.” Cochran currently resides in Rock Hill, South Carolina where she is an active member of Westminster Presbyterian Church.

About Capital Bank

Capital Bank, N.A.was formed in July 2010 as the banking subsidiary of North American Financial Holdings, Inc., a bank holding company incorporated in 2009 with the goal of creating a regional banking franchise in the Southeastern United States. With approximately $7 billion in total assets and more than 1,500 employees, Capital Bank offers a broad range of financial services and operates 146 branches in Florida, North Carolina, South Carolina, Tennessee and Virginia. More information on Capital Bank is available at www.capitalbank-us.com.